Anti-CD40 monoclonal antibody

Details for Australian Patent Application No. 2002251562 (hide)

International Classifications

Event Publications

17 April 2003 Application Open to Public Inspection

Published as AU-B-2002251562

14 December 2006 Application Accepted

Published as AU-B-2002251562

21 December 2006 Amendment Made

The nature of the amendment is: Add priority details 09/844,684 US 9 September 2002 2003

8 March 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2E(2). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

26 April 2007 Section 223 Application Allowed

Kirin Beer Kabushiki Kaisha The time in which to pay the examination response fee has been extended to 01 Mar 2007. Address for service in Australia - FB Rice & Co Level 23 44 Market Street SYDNEY NSW 2000 2003

23 August 2007 Standard Patent Sealed

4 October 2007 Change of Name(s) of Applicant(s), Section 104

Kirin Beer Kabushiki Kaisha The name of the applicant has been changed to Kirin Holdings Kabushiki Kaisha

29 November 2007 Assignment Registered

Kirin Holdings Kabushiki Kaisha The patent has been assigned to Kirin Pharma Kabushiki Kaisha

8 January 2009 Alteration of Name

The name of the patentee has been altered to Kyowa Hakko Kirin Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.